MARKET

ANRO

ANRO

Alto Neuroscienc
NYSE
23.59
+0.74
+3.24%
Closed 17:41 05/14 EDT
OPEN
22.00
PREV CLOSE
22.85
HIGH
23.91
LOW
21.93
VOLUME
509.84K
TURNOVER
0
52 WEEK HIGH
28.44
52 WEEK LOW
2.150
MARKET CAP
827.87M
P/E (TTM)
-10.7628
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Radnet (RDNT)
TipRanks · 1d ago
Alto Neuroscience Is Maintained at Neutral by Wedbush
Dow Jones · 1d ago
Alto Neuroscience Price Target Raised to $24.00/Share From $21.00 by Wedbush
Dow Jones · 1d ago
Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $24
Benzinga · 1d ago
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained
TipRanks · 1d ago
Ritu Baral Reiterates Buy on Alto Neuroscience, Citing Pivotal ALTO-207 Phase 2b Trial in TRD and Strong Cash Runway Through 2029
TipRanks · 1d ago
Alto Neuroscience Shareholders Shape Governance and Equity Plans
TipRanks · 1d ago
Analysts’ Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), BioLife Solutions (BLFS)
TipRanks · 1d ago
More
About ANRO
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company focused on redefining psychiatry by leveraging neurobiology to develop personalized and effective treatment options. The Company's Precision Psychiatry Platform measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to identify which patients are likely to respond to its product candidates. Its clinical-stage pipeline includes drug candidates in bipolar depression, major depressive disorder, treatment resistant depression (TRD), and schizophrenia, and other mental health conditions. Its product candidates include ALTO-100, ALTO-300, ALTO-207, ALTO-203, ALTO-101, ALTO-202, and ALTO-208. ALTO-100 is a first-in-class, oral small molecule believed to work through enhancing neural plasticity in the hippocampus, a brain region important for both cognition and mood. ALTO-203 is an oral small molecule histamine H3 receptor inverse agonist.

Webull offers Alto Neuroscience Inc stock information, including NYSE: ANRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANRO stock methods without spending real money on the virtual paper trading platform.